advertisement
Lee DA 17
Showing records 1 to 17 | Display only abstracts from Lee DA in IGR 25-1120868 ChatGPT: is it good for our glaucoma patients?
Wu G; Lee DA; Zhao W; Wong A; Sidhu S
Frontiers in ophthalmology 2023; 3: 1260415 (IGR: 25-1)
70785 Agreement between Gonioscopic Examination and Swept Source Fourier Domain Anterior Segment Optical Coherence Tomography Imaging
Rigi M; Bell NP; Lee DA; Baker LA; Chuang AZ; Nguyen D; Minnal VR; Feldman RM; Blieden LS
Journal of Ophthalmology 2016; 2016: 1727039 (IGR: 18-2)
65900 Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
Queen JH; Feldman RM; Lee DA
American Journal of Ophthalmology 2016; 163: 70-74.e1 (IGR: 17-3)
59104 Trabecular-iris circumference volume in open angle eyes using swept-source fourier domain anterior segment optical coherence tomography
Rigi M; Blieden LS; Nguyen D; Chuang AZ; Baker LA; Bell NP; Lee DA; Mankiewicz KA; Feldman RM
Journal of Ophthalmology 2014; 2014: 590978 (IGR: 16-3)
54623 Risk factors for tube shunt exposure: a matched case-control study
Koval MS; El Sayyad FF; Bell NP; Chuang AZ; Lee DA; Hypes SM; Grover DS; Baker LA; Huddleston SM; Budenz DL; Feldman RM
Journal of Ophthalmology 2013; 2013: 196215 (IGR: 15-3)
46811 Aqueous shunt exposure: A retrospective review of repair outcome
Huddleston SM; Feldman RM; Budenz DL; Bell NP; Lee DA; Chuang AZ; Mankiewicz KA; Koval MS; Truong E; Moraczewski A
Journal of Glaucoma 2011; (IGR: 13-3)
24505 "Bleb window"-pexy for the management of symptomatic, oversized blebs
Tabet R; Feldman RM; Bell NP; Lee DA
Journal of Glaucoma 2009; 18: 546-551 (IGR: 11-3)
10122 Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
Whitson JT; Henry C; Hughes B; Lee DA; Terry S; Fechtner RD
Journal of Glaucoma 2004; 13: 168-173 (IGR: 6-1)
8152 Automated perimetry: A report by the American Academy of Ophthalmology
Delgado MF; Nguyen NTA; Cox TA; Singh K; Lee DA; Dueker DK; Fechtner RD; Juzych MS; Lin SC; Netland PA
Ophthalmology 2002; 109: 2362-2374 (IGR: 4-3)
6463 Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial
Lee DA; Gornbein JA
Journal of Glaucoma 2001; 10: 220-226 (IGR: 3-2)
15851 Emerging perspectives on glaucoma: highlights of a round table discussion
Lee DA
American Journal of Ophthalmology 2000; 130: 1-11 (IGR: 2-3)
5789 Efficacy of brimonidine as replacement therapy in patients with open-angle glaucoma or ocular hypertension
Lee DA
Clinical Therapeutics 2000; 22:53-65 (IGR: 2-1)
5790 The effectiveness and safety of brimonidine as mono-, combination, or replacement therapy for patients with primary open-angle glaucoma or ocular hypertension: a post hoc analysis of an open-label community trial: Glaucoma Trial Study Group
Lee DA; Gornbein J; Abrams C
Journal of Ocular Pharmacology and Therapeutics 2000; 16:3-18 (IGR: 2-1)
5846 Collagen degradation in glaucoma: will it gain a therapeutic value?
La Rosa FA; Lee DA
Current Opinions in Ophthalmology 2000; 11: 90-93 (IGR: 2-1)
5879 The effect of integrin antibodies on the attachment and proliferation of human Tenon's capsule fibroblasts
Paikal D; Zhang G; Cheng Q; Lee DA
Experimental Eye Research 2000; 70: 393-400 (IGR: 2-1)
5415 Audible pops during cyclodiode procedures
Altuna JC; Greenfield DS; Wand M; Liebmann JM; Taglia DP; Kaufmann PL; Cioffi GA; Lee DA; Robin AL; Crichton A
Journal of Glaucoma 1999; 8: 177-183 (IGR: 1-2)
5434 The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications
Le HH; Chang MR; Cheng Q; Lee DA; Hartenbaum D
Journal of Ocular Pharmacology and Therapeutics 1999; 15: 305-312 (IGR: 1-2)